Title
Category
Credits
Event date
Cost
  • Disease management
  • Wellness
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Addressing the multifaceted nature of patients’ wellbeing requires an understanding of the value of integrated medical and behavioral health care in providing holistic and high-quality patient care. This activity will delve into the significance of combined physical and behavioral health treatments on patient outcomes and discuss the key components of evidence-based integrated behavioral health models. Participants will also examine hurdles to adopting these integrated models, including systemic and cultural barriers, to better enable them to advocate for and navigate the provision of whole-person health care.
  • Disease management
  • Wellness
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
Obesity is a chronic health condition and a leading cause of chronic diseases in adults and children. Lifestyle changes with the use of medication is a nonsurgical management strategy to promote weight loss and lessen the effects of these conditions caused or exacerbated by obesity. This activity will discuss how to effectively assess for obesity and provide nonsurgical management interventions through helping patients commit to lifestyle changes and the use of pharmacotherapies.
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
$0.00
This educational webcast is designed to enhance primary care providers’ competency in managing headaches with a focus on evidence-based approaches. Participants will engage in a comprehensive review of migraine pathophysiology to better recognize and differentiate migraine symptoms. The session will examine traditional therapies for migraine, both acute and preventive, and introduce cutting-edge anti-calcitonin gene-related peptide (CGRP) targeted therapies. It will compare the efficacy and application of these treatments, enabling informed decision-making in clinical practice. The program will also explore the application of anti-CGRP therapies beyond migraines, considering their role in treating a variety of headache and facial-pain conditions.